Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Novacyt
Novacyt
Activities:
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Novacyt launches assays for SARS-CoV-2 variants
Novacyt’s existing polymerase chain reaction (PCR) COVID-19 portfolio remains highly accurate in detecting all published SARS-CoV-2 variants, the company says
Finance
Novacyt signs contract to supply PCR instruments to UK DHSC
This is the second major contract awarded by the DHSC to Primerdesign, Novacyt’s molecular diagnostics division, during the COVID-19 pandemic
Regulatory
French institute approves Novacyt COVID-19 test
The CNR approval has meant the CE-Mark test is available in markets which directly accept CE-Mark accreditation without the need for further approval
Finance
Novacyt reports increased sales and new deals for outbreak diagnostics
France-based Novacyt has provided an update on its business moves that have resulted from the novel COVID-19
Infection Control
Novacyt launches novel coronavirus test
The Primerdesign coronavirus test has the ability to detect only the 2019 strain of the virus
Finance
Novacyt completes substantial q16 molecular diagnostics order
Expands clinical diagnostic reach in fast growing Chinese market
Subscribe now